October 1 update. Our PDGM and ICD-10 tools now use the FY2027 code set: 190 codes added, 30 deleted, and no existing code changed clinical group.

See what changed

ICD-10 · PDGM grouping

C50-C50 — Malignant neoplasms of breast

Every ICD-10-CM code in this range and the PDGM clinical group CMS assigns to it, read from the CMS grouper crosswalk v07.2.26.

ICD-10-CM FY2027 · CMS grouper v07.2.26

Codes in range

57

No clinical group

19

A period cannot be grouped from these.

Barred as primary

0

CMS rejects these in the primary position.

Where these codes group

38 of the 57 codes in C50-C50 group to MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases. A further 19 are assigned no clinical group at all, which means a 30-day period cannot be grouped from them.

Code families in C50-C50

One page per three-character family: every code in it, whether it can lead a claim, its clinical group and comorbidity subgroup.

Every code in C50-C50

Descriptions are CMS’s own, abbreviated as CMS abbreviates them.

CodeDescriptionClinical groupPrimary position
C50011Malignant neoplasm of nipple and areola, right female breastKCan lead a claim
C50012Malignant neoplasm of nipple and areola, left female breastKCan lead a claim
C50019Malignant neoplasm of nipple and areola, unsp female breastNoneCannot lead a claim
C50021Malignant neoplasm of nipple and areola, right male breastKCan lead a claim
C50022Malignant neoplasm of nipple and areola, left male breastKCan lead a claim
C50029Malignant neoplasm of nipple and areola, unsp male breastNoneCannot lead a claim
C50111Malignant neoplasm of central portion of right female breastKCan lead a claim
C50112Malignant neoplasm of central portion of left female breastKCan lead a claim
C50119Malignant neoplasm of central portion of unsp female breastNoneCannot lead a claim
C50121Malignant neoplasm of central portion of right male breastKCan lead a claim
C50122Malignant neoplasm of central portion of left male breastKCan lead a claim
C50129Malignant neoplasm of central portion of unsp male breastNoneCannot lead a claim
C50211Malig neoplm of upper-inner quadrant of right female breastKCan lead a claim
C50212Malig neoplasm of upper-inner quadrant of left female breastKCan lead a claim
C50219Malig neoplasm of upper-inner quadrant of unsp female breastNoneCannot lead a claim
C50221Malig neoplasm of upper-inner quadrant of right male breastKCan lead a claim
C50222Malig neoplasm of upper-inner quadrant of left male breastKCan lead a claim
C50229Malig neoplasm of upper-inner quadrant of unsp male breastNoneCannot lead a claim
C50311Malig neoplm of lower-inner quadrant of right female breastKCan lead a claim
C50312Malig neoplasm of lower-inner quadrant of left female breastKCan lead a claim
C50319Malig neoplasm of lower-inner quadrant of unsp female breastNoneCannot lead a claim
C50321Malig neoplasm of lower-inner quadrant of right male breastKCan lead a claim
C50322Malig neoplasm of lower-inner quadrant of left male breastKCan lead a claim
C50329Malig neoplasm of lower-inner quadrant of unsp male breastNoneCannot lead a claim
C50411Malig neoplm of upper-outer quadrant of right female breastKCan lead a claim
C50412Malig neoplasm of upper-outer quadrant of left female breastKCan lead a claim
C50419Malig neoplasm of upper-outer quadrant of unsp female breastNoneCannot lead a claim
C50421Malig neoplasm of upper-outer quadrant of right male breastKCan lead a claim
C50422Malig neoplasm of upper-outer quadrant of left male breastKCan lead a claim
C50429Malig neoplasm of upper-outer quadrant of unsp male breastNoneCannot lead a claim
C50511Malig neoplm of lower-outer quadrant of right female breastKCan lead a claim
C50512Malig neoplasm of lower-outer quadrant of left female breastKCan lead a claim
C50519Malig neoplasm of lower-outer quadrant of unsp female breastNoneCannot lead a claim
C50521Malig neoplasm of lower-outer quadrant of right male breastKCan lead a claim
C50522Malig neoplasm of lower-outer quadrant of left male breastKCan lead a claim
C50529Malig neoplasm of lower-outer quadrant of unsp male breastNoneCannot lead a claim
C50611Malignant neoplasm of axillary tail of right female breastKCan lead a claim
C50612Malignant neoplasm of axillary tail of left female breastKCan lead a claim
C50619Malignant neoplasm of axillary tail of unsp female breastNoneCannot lead a claim
C50621Malignant neoplasm of axillary tail of right male breastKCan lead a claim
C50622Malignant neoplasm of axillary tail of left male breastKCan lead a claim
C50629Malignant neoplasm of axillary tail of unsp male breastNoneCannot lead a claim
C50811Malignant neoplasm of ovrlp sites of right female breastKCan lead a claim
C50812Malignant neoplasm of ovrlp sites of left female breastKCan lead a claim
C50819Malignant neoplasm of ovrlp sites of unsp female breastNoneCannot lead a claim
C50821Malignant neoplasm of overlapping sites of right male breastKCan lead a claim
C50822Malignant neoplasm of overlapping sites of left male breastKCan lead a claim
C50829Malignant neoplasm of overlapping sites of unsp male breastNoneCannot lead a claim
C50911Malignant neoplasm of unsp site of right female breastKCan lead a claim
C50912Malignant neoplasm of unspecified site of left female breastKCan lead a claim
C50919Malignant neoplasm of unsp site of unspecified female breastNoneCannot lead a claim
C50921Malignant neoplasm of unspecified site of right male breastKCan lead a claim
C50922Malignant neoplasm of unspecified site of left male breastKCan lead a claim
C50929Malignant neoplasm of unsp site of unspecified male breastNoneCannot lead a claim
C50A0Malignant inflammatory neoplasm of unspecified breastNoneCannot lead a claim
C50A1Malignant inflammatory neoplasm of right breastKCan lead a claim
C50A2Malignant inflammatory neoplasm of left breastKCan lead a claim

Source: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.

The monthly home health regs digest

What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue